CD4+ T helper 1 (Th1) cells mediate anti-tumor effects with the help of CD8+ T cells [50], hence, elevated numbers of CD4+ T helper 1 cells in the TME correlate with a positive clinical outcome in various human tumors (rev. The gene discussed is CD8A; the disease is neoplasm.